Curadev Pharma Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Curadev Pharma Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11208
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Curadev Pharma Pvt Ltd (Curadev Pharma) is a small molecule drug discovery company that manufactures, discovers, and delivers formulations. The company manufactures formulations and APIs such as cyclodextrin in collaboration with the University of Greenwich and creates and out-licenses pre-IND assets and IND packages for drug development. Its pipeline spans indications for liquid tumors, breast cancer, and inflammation, solid tumors. Curadev Pharma has developed potent small molecules inhibitors that reduce kynurenine levels in experimental paradigms. The company conducts research in the areas of GPCR biology, special cell lines, ADME/PK assessment of compounds, blood-brain barrier, and kinase enzymology and incubated its drug discovery chemistry labs in the Indian Institute of Technology, Kanpur. Curadev Pharma is headquartered in Noida, Uttar Pradesh, India.

Curadev Pharma Pvt Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Curadev Pharma Plans To Raise Up To US$12 Million In Private Equity Financing 10
Partnerships 11
Curadev Pharma Enters into Research Partnership with University of Texas Southwestern Medical Center 11
Licensing Agreements 12
TCG Lifesciences Enters into Licensing Agreement with Curadev Pharma 12
Curadev Pharma Enters into Licensing Agreement with Roche 13
Curadev Pharma Pvt Ltd – Key Competitors 14
Curadev Pharma Pvt Ltd – Key Employees 15
Curadev Pharma Pvt Ltd – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
May 31, 2017: Professor Satyajit Rath joins Curadev’s Scientific Advisory Board 17
Product News 18
10/31/2017: Curadev Presents on its STING program at the AACR Tumor Immunology and Immunotherapy Meeting 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curadev Pharma Pvt Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Curadev Pharma Plans To Raise Up To US$12 Million In Private Equity Financing 10
Curadev Pharma Enters into Research Partnership with University of Texas Southwestern Medical Center 11
TCG Lifesciences Enters into Licensing Agreement with Curadev Pharma 12
Curadev Pharma Enters into Licensing Agreement with Roche 13
Curadev Pharma Pvt Ltd, Key Competitors 14
Curadev Pharma Pvt Ltd, Key Employees 15

List of Figures
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curadev Pharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Curadev Pharma Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Manila Electric Co (MER):電力:M&Aディール及び事業提携情報
    Summary Manila Electric Co (MERALCO) is an electric distribution utility company. It constructs, operates and maintains the electricity distribution system in the cities and municipalities of Bulacan, Metro Manila, Cavite, and Rizal and certain cities, municipalities, and barangays in the provinces …
  • Dragon Oil Plc:企業の戦略的SWOT分析
    Dragon Oil Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Ono Pharmaceutical Co., Ltd.:企業の戦略・SWOT・財務分析
    Ono Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ono Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Owens Corning (OC):企業の財務・戦略的SWOT分析
    Owens Corning (OC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Silgan Holdings Inc.:企業の戦略・SWOT・財務分析
    Silgan Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Silgan Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Forward Industries, Inc. (FORD):企業の財務・戦略的SWOT分析
    Forward Industries, Inc. (FORD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Tokyo Electric Power Company Holdings Incorporated (9501):企業の財務・戦略的SWOT分析
    Tokyo Electric Power Company Holdings Incorporated (9501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the compan …
  • Fidelidade – Companhia de Seguros, S.A.:企業の戦略・SWOT・財務情報
    Fidelidade - Companhia de Seguros, S.A. - Strategy, SWOT and Corporate Finance Report Summary Fidelidade - Companhia de Seguros, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • International AIDS Vaccine Initiative-製薬・医療分野:企業M&A・提携分析
    Summary International AIDS Vaccine Initiative (IAVI) is a not-for-profit organization that develops preventive HIV vaccine candidates. The organization offers vaccine development through basic research, discovery, preclinical evaluation and manufacturing, and regulatory review, among others. It also …
  • Public Financial Holdings Ltd (626):企業の財務・戦略的SWOT分析
    Public Financial Holdings Ltd (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Kuwait Oil Co:企業の戦略的SWOT分析
    Kuwait Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Griffon Corporation:企業の戦略・SWOT・財務分析
    Griffon Corporation - Strategy, SWOT and Corporate Finance Report Summary Griffon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ecolab Inc.:企業の戦略・SWOT・財務分析
    Ecolab Inc. - Strategy, SWOT and Corporate Finance Report Summary Ecolab Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • DreamWorks Animation LLC:企業の戦略的SWOT分析
    DreamWorks Animation LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Takasago International Corporation (4914):企業の財務・戦略的SWOT分析
    Takasago International Corporation (4914) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Center Parcs (Holdings 1) Limited:企業の戦略・SWOT・財務情報
    Center Parcs (Holdings 1) Limited - Strategy, SWOT and Corporate Finance Report Summary Center Parcs (Holdings 1) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Pension Insurance Corporation plc:企業の戦略・SWOT・財務情報
    Pension Insurance Corporation plc - Strategy, SWOT and Corporate Finance Report Summary Pension Insurance Corporation plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Flex Foods Ltd:企業の戦略・SWOT・財務情報
    Flex Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary Flex Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Aluminium Bahrain BSC (ALBH):企業の財務・戦略的SWOT分析
    Aluminium Bahrain BSC (ALBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ZWACK Unicum Nyrt:企業の戦略・SWOT・財務情報
    ZWACK Unicum Nyrt - Strategy, SWOT and Corporate Finance Report Summary ZWACK Unicum Nyrt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆